Warning! GuruFocus detected
2 Severe warning signs
with AGL.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Agilon Health Inc
NAICS : 623312
SIC : 8099
ISIN : US00857U1079
Compare
Compare
Traded in other countries / regions
AGL.USA Index Membership
Russell 2000Russell 3000Russell 1000 IPO Date
2021-04-15Description
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.64 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.19 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.73 | |||||
| Beneish M-Score | 7.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 53.5 | |||||
| 3-Year EBITDA Growth Rate | 18.2 | |||||
| 3-Year EPS without NRI Growth Rate | 16.3 | |||||
| 3-Year FCF Growth Rate | 17.7 | |||||
| 3-Year Book Growth Rate | -25.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 42.19 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 9.01 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.47 | |||||
| 9-Day RSI | 35.5 | |||||
| 14-Day RSI | 41.32 | |||||
| 3-1 Month Momentum % | 24.1 | |||||
| 6-1 Month Momentum % | 73.64 | |||||
| 12-1 Month Momentum % | -12.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.27 | |||||
| Quick Ratio | 1.27 | |||||
| Cash Ratio | 0.35 | |||||
| Days Sales Outstanding | 76.32 | |||||
| Days Payable | 77.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1 | |||||
| Shareholder Yield % | 0.23 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 0.08 | |||||
| Operating Margin % | -4.76 | |||||
| Net Margin % | -4.29 | |||||
| FCF Margin % | -1.63 | |||||
| ROE % | -42.32 | |||||
| ROA % | -12.95 | |||||
| ROIC % | -90.53 | |||||
| 3-Year ROIIC % | 158.94 | |||||
| ROC (Joel Greenblatt) % | -284.88 | |||||
| ROCE % | -33.76 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.27 | |||||
| PB Ratio | 3.42 | |||||
| Price-to-Tangible-Book | 4.29 | |||||
| EV-to-EBIT | -5.02 | |||||
| EV-to-EBITDA | -5.59 | |||||
| EV-to-Revenue | 0.2 | |||||
| EV-to-Forward-Revenue | 0.24 | |||||
| EV-to-FCF | -12.31 | |||||
| Price-to-GF-Value | 0.11 | |||||
| Price-to-Net-Current-Asset-Value | 8.3 | |||||
| Earnings Yield (Greenblatt) % | -19.92 | |||||
| FCF Yield % | -6.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:AGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Agilon Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,060.53 | ||
| EPS (TTM) ($) | -0.63 | ||
| Beta | -0.04 | ||
| 3-Year Sharpe Ratio | -0.33 | ||
| 3-Year Sortino Ratio | -0.46 | ||
| Volatility % | 109.25 | ||
| 14-Day RSI | 41.32 | ||
| 14-Day ATR ($) | 0.467595 | ||
| 20-Day SMA ($) | 4.5755 | ||
| 12-1 Month Momentum % | -12.67 | ||
| 52-Week Range ($) | 1.5 - 7.73 | ||
| Shares Outstanding (Mil) | 413 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Agilon Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Agilon Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Agilon Health Inc Frequently Asked Questions
What is Agilon Health Inc(AGL)'s stock price today?
The current price of AGL is $3.90. The 52 week high of AGL is $7.73 and 52 week low is $1.50.
When is next earnings date of Agilon Health Inc(AGL)?
The next earnings date of Agilon Health Inc(AGL) is 2025-05-06.
Does Agilon Health Inc(AGL) pay dividends? If so, how much?
Agilon Health Inc(AGL) does not pay dividend.
Guru Commentaries on NYSE:AGL
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers